{
    "nctId": "NCT01016028",
    "briefTitle": "Chemotherapy-Induced Peripheral Neuropathy Survey",
    "officialTitle": "Chemotherapy-Induced Peripheral Neuropathy: Feasibility and Validity of New Symptom Measurement Tools in Patients on Treatment With Platinum Agents, Taxanes and Bortezomib",
    "overallStatus": "WITHDRAWN",
    "conditions": "Breast Cancer, Colorectal Cancer, Myeloma, Chemotherapy-induced Peripheral Neuropathy",
    "studyType": "OBSERVATIONAL",
    "phase": "N/A",
    "allocation": "N/A",
    "primaryPurpose": "N/A",
    "enrollmentCount": 0,
    "primaryOutcomeMeasure": "Assessment of Patient's Symptoms (Questionnaire)",
    "eligibilityCriteria": "Inclusion Criteria:\n\n1. Patients \\>= 18 years old.\n2. Patients must be fluent with the English language.\n3. Patients must be on chemotherapy regimes with any of the study drugs: cisplatin, oxaliplatin, taxanes and/or bortezomib.\n\nExclusion Criteria:\n\n1. Significant cognitive impairment as determined by the trained research staff\n2. Chronic alcoholism or substance abuse\n3. Diagnosis of severe depression",
    "sex": "ALL",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}